Elimination of Buprenorphine Dose Limits
The WSMA supports flexibility in dosing of buprenorphine by elimination of
non-evidence-based dose limits imposed by clinics, health systems,
pharmacies, and insurance carriers. (Res B-5, A-23)
Return to the WSMA Policy Compendium index
Abbreviations for House of Delegates report origination:
EC – Executive Committee; BT – Board of Trustees; CPA – Council on
Professional Affairs; JC – Judicial Council; CHS – Community and Health
Services